Sickle cell disease is a genetic hematological condition with multi-system manifestations. Various genotypes of the condition exist, each with their own risk of ocular manifestations. Sickle cell retinopathy, one of the more common ocular manifestations of sickle cell disease, can be potentially blinding and must be appropriately screened for, detected, and treated when necessary. Though there are no universally adopted preferred practice guidelines for the optometric/ophthalmic management of sickle cell retinopathy this course will provide attendees a foundation on sickle cell disease, the ocular manifestations of sickle cell disease, and the appropriate management of these patients. Case images will be presented and a discussion of when/who to refer will be included.

Course Code:



Daniel Epshtein, O.D.

Alanna Khattar-Sullivan, O.D.



AOA Expiration Date:


Related News

Constant presence: Alliance builds reputation for patient safety advocacy

Founded five years ago, the Health Care Alliance for Patient Safety (HCAPS) is making good on its mission to advocate for patient safety and protect the fundamental doctor-patient relationship. The alliance’s advocacy will be recognized with the AOA’s Apollo Award during a ceremony at the 2023 Optometry’s Meeting® June 21-24.

What defines the value of care we provide?

Health and vision plans have not adapted and grown with the care we deliver but hold back optometry’s momentum.

How to speak the universal language of care

How to create a bilingual and culturally sensitive practice, why it matters to patients and how it can set you apart from the competition.